Saccharomyces boulardii inhibits EGF receptor signaling and intestinal tumor growth in Apc(min) mice.
Saccharomyces boulardii inhibits EGF receptor signaling and intestinal tumor growth in Apc(min) mice.
复制标题
DOI:
10.1053/j.gastro.2009.05.050
复制
发表时间:
2009-09
期刊:
影响因子:
29.4
通讯作者:
Kelly CP
中科院分区:
文献类型:
--
作者:
Chen X;Fruehauf J;Goldsmith JD;Xu H;Katchar KK;Koon HW;Zhao D;Kokkotou EG;Pothoulakis C;Kelly CP
Saccharomyces boulardii (Sb) is a probiotic yeast with anti-inflammatory and antimicrobial activities and has been used for decades in the prevention and treatment of a variety of human gastrointestinal disorders. We reported previously that Sb modulates host inflammatory responses through down regulation of Erk1/2 MAP kinase activities both in vitro and in vivo. The aim of this study was to identify upstream mediators responsible for Erk1/2 inactivation and to examine the effects of Sb on tumor development in ApcMin mice. We found that the EGF receptor was deactivated upon exposure to Sb leading to inactivation of both the EGFR-Erk and EGFR-Akt pathways. In human colonic cancer cells, Sb prevented EGF induced proliferation, reduced cell colony formation and promoted apoptosis. HER-2, HER-3 and IGF-1R were also found to be inactivated by Sb. Oral intake of Sb reduced intestinal tumor growth and dysplasia in C57BL/6J Min/+ (ApcMin) mice. Thus, in addition to its anti-inflammatory effects, S. boulardii inhibits EGFR and other receptor tyrosine kinase signaling and thereby may also serve a novel therapeutic or prophylactic role in intestinal neoplasia.
登录
查看更多内容
影响因子:
29.4
作者:
Dalmasso, Guillaume;Cottrez, Francoise;Groux, Herve
通讯作者:
Groux, Herve
影响因子:
29.4
作者:
POTHOULAKIS, C;KELLY, CP;LAMONT, JT
通讯作者:
LAMONT, JT
影响因子:
3.4
作者:
de Castro-Carpeno, Javier;Belda-Iniesta, Cristobal;Gonzalez Baron, Manuel
通讯作者:
Gonzalez Baron, Manuel
影响因子:
4.3
作者:
Ponz-Sarvise, M.;Rodriguez, J.;Gil-Bazo, I.
通讯作者:
Gil-Bazo, I.
影响因子:
3.1
作者:
BUTS, JP;BERNASCONI, P;DIVE, C
通讯作者:
DIVE, C